Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Healthtrust
Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson

Generated: May 24, 2019

DrugPatentWatch Database Preview

Bionpharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?

BIONPHARMA INC has twenty-eight approved drugs.

There are four US patents protecting BIONPHARMA INC drugs.

There are ten patent family members on BIONPHARMA INC drugs in thirteen countries and twenty-nine supplementary protection certificates in eleven countries.

Summary for Bionpharma Inc
International Patents:10
US Patents:4
Tradenames:26
Ingredients:23
NDAs:28
Drug Master File Entries: 2
Patent Litigation for Bionpharma Inc: See patent lawsuits for Bionpharma Inc

Drugs and US Patents for Bionpharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 209753-003 Mar 2, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Bionpharma Inc IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 090397-001 Nov 22, 2010 OTC No No ➤ Sign Up ➤ Sign Up
Bionpharma Inc LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 021855-002 Aug 4, 2005 OTC Yes Yes ➤ Sign Up ➤ Sign Up
Bionpharma Inc CALCITRIOL calcitriol CAPSULE;ORAL 091174-001 May 24, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Bionpharma Inc AZITHROMYCIN azithromycin TABLET;ORAL 209999-001 Dec 26, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Bionpharma Inc BENZONATATE benzonatate CAPSULE;ORAL 081297-002 Oct 30, 2007 AA RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Bionpharma Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0387077 SPC/GB04/003 United Kingdom ➤ Sign Up PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721
0663828 C300085 Netherlands ➤ Sign Up PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
0637297 SPC/GB01/041 United Kingdom ➤ Sign Up SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB01/041 GRANTED TO EISAI R + D MANAGEMENT., LTD. IN RESPECT OF THE PRODUCT BEXAROTENE (4-(1-(3, 5, 5, 8, 8-PENTAMETHYL-5, 6, 7, 8-TETRAHYDRO-2-NAPHTHALENYL)VINYL)BENZOIC ACID), WHICH WAS ADVERTISED AS COMING INTO FORCE IN JOURNAL NO 6469 DATED 15/05/2013 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, IT WILL EXPIRE ON 01/04/2016.
0637297 01C0027 France ➤ Sign Up PRODUCT NAME: BEXAROTENE; REGISTRATION NO/DATE: EU/1/01/178/001 20010329
0152897 SPC/GB01/012 United Kingdom ➤ Sign Up PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
1411900 1190013-1 Sweden ➤ Sign Up PRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
US Army
Colorcon
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.